Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Semih Başcı

7PUBLICATIONS
43CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesAnaesthesiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Jul 20, 2024
Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience.

Samet Yaman, Semih Başci, Ersin Bozan

|Sep 13, 2021
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.

Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden

|Jun 10, 2021
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers.

Semih Başcı, Naim Ata, Fevzi Altuntaş

|May 06, 2021
COVID-19 clinical course and blood groups: Turkish population-based study

Mehmet Sinan Dal, Naim Ata, Fevzi Altuntaş

|Nov 25, 2020
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience

Hikmettullah Batgi, Semih Başcı, Mehmet Sinan Dal

|Oct 21, 2020
Tyrosine kinase inhibitors and COVID-19.

Başcı Semih, Yiğenoğlu Tuğçe Nur, Dal Mehmet Sinan

Pageof 2

Frequent Collaborators

3 joint publications

Mehmet Sinan Dal

3 joint publications

Tuğçe Nur Yiğenoğlu

3 joint publications

Fevzi Altuntaş

2 joint publications

Merih Kızıl Çakar

2 joint publications

Bahar Uncu Ulu

2 joint publications

Serdal Korkmaz

1 joint publications

Samet Yaman

1 joint publications

Burcu Aslan Candir

1 joint publications

Meliha Nalçacı

1 joint publications

Nurgül Özcan

Frequent Collaborators

3 joint publications

Mehmet Sinan Dal

3 joint publications

Tuğçe Nur Yiğenoğlu

3 joint publications

Fevzi Altuntaş

2 joint publications

Merih Kızıl Çakar

Top Related Videos

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on : Nov 08, 2015

16.9K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.6K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on : Mar 10, 2023

4.2K
See more related videos

Top Related Videos

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on : Nov 08, 2015

16.9K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.6K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on : Mar 10, 2023

4.2K
See more related videos